News Briefs

Last Chance to Register for the 2015 Practice Management Workshop
The 2015 AAAAI Practice Management Workshop will be held July 17-19 in Denver. Registration closes July 13, 2015 at 11:59 pm. Read more »

CMS, AMA Transition Initiatives to Lead Providers into ICD-10 Deadline
Critical changes address claim denials, penalties and payment disruptions. CMS will also establish a communication center to monitor and resolve issues. Read more »

2016 Annual Meeting Website Now Open for Abstract Submission
Are you looking to contribute to the allergy/immunology research showcased at the 2016 AAAAI Annual Meeting in Los Angeles? Read more »

Join Us for Back-to-School Twitter Chat
AAAAI is hosting a Twitter chat with Allergic Living on August 19. Read more »

Live Courses Improve Care for Severe Asthma, Allergic Skin Conditions
Register for the “Severe Asthma: Clinical Communication to Improve Control” live course in Denver or join us at the "Allergic Contact Dermatitis and Eczema in the Allergy Practice" live course in Arlington. Read more »

2016 AAAAI/ACAAI Joint Board Review Course Registration Opens July 14
Registration for the upcoming 2016 AAAAI/ACAAI Certification/Maintenance of Certification Board Review Course will officially open on July 14. Read more »

Now is the Time to Join an AAAAI Committee
If you’ve been thinking about joining one of the AAAAI’s committees, now is the time to get involved. The 2016-2017 committee appointment process is underway. Read more »

2015 Virtual Annual Meeting Available for Purchase
The 2015 Virtual Annual Meeting offers recordings from over 100 key sessions from Houston. Did you know that you can use the recordings toward your PI: Pro Self-Assessment learning plan? Read more »

Join the Virtual Journal Club with JACI: In Practice
Register for this live webinar on August 5. Two new, clinically relevant articles from JACI: In Practice will be discussed. Read more »

UpToDate Discount for AAAAI Members
The AAAAI and UpToDate® have partnered to provide you a special subscription offer on UpToDate, the clinical decision support resource medical trainees and physicians trust for reliable clinical answers. Read more »

FDA Alert: Monoclonal Antibodies (mAb) to Target Interleukin-5 (IL-5)
An advisory panel has recommended mepolizumab for approval and the FDA has also accepted an application for reslizumab. Read more »

View This Month’s Featured Jobs in the AAAAI Career Connections Center
Browse the latest allergy/immunology openings from top employers in the AAAAI’s Career Connections Center. Read more »